AstraZeneca's new precision biologic gets FDA approval to treat severe eosinophilic asthma - News-Medical.net

News-Medical.net

AstraZeneca's new precision biologic gets FDA approval to treat severe eosinophilic asthma News-Medical.net AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has approved FASENRA™ (benralizumab) for the add-on maintenance treatment of patients with severe ... AstraZeneca gets FDA nod for severe eosinophilic asthma drugKorea Biomedical Review all 4 news articles »

from Health - Google News http://ift.tt/2ALJyLB